Oncohematology and Genetics

Investigación Molecular y Traslacional en Oncología

Javier Salvador Bofill
Javier Salvador Bofill

Javier Salvador Bofill

Back to program
  1. Group members
  2. Research areas
  3. Publications

Group: Investigación Molecular y Traslacional en Oncología

Directory
Foto no disponible
  • Molina Pinelo, Sonia.Investigadora Nicolás Monardes UGC Oncología Médica Doctora en Biología
  • Alonso García, Miriam.Lda. en Medicina y Cirugía
  • Benavent Viñuales, Marta.Dra. en Medicina y Cirugía
  • Benedetti Pedroza, Johana.Lda. en Medicina y Cirugía
  • Bernabé Caro, Reyes.Dra. en Medicina y Cirugía
  • Boyero Corral, Laura.Doctora en Bioquímica y Biología Molecular
  • Castilla Moro, María de los Ángeles.Doctora en Biología Molecular
  • Domínguez Cejudo, María de los Ángeles.Doctora en Biotecnología
  • Fernández Márquez, Fátima.Ingeniera de Caminos, Canales y Puertos.
  • Galindo Pérez de Azpillaga, Carlos.Ldo. en Administración y Dirección de Empresas
  • Garrigos Vacas, Carmen.Dra. en Farmacia
  • Gil Torralvo, Ana.Lda. en Medicina y Cirugía
  • Muñoz Fuentes, Miguel Ángel.Dr. en Químicas
  • Noguera Ucles, José Francisco.Ldo. en Bioquímica
  • Pérez Valderrama, Begoña.Lda. en Medicina y Cirugía
  • Ruíz Borrego, Manuel.Ldo. en Medicina y Cirugía
  • Salinas Villegas, Ana.Técnica de Laboratorio de Diagnóstico Clínico
  • Salvador Bofill, Javier.Jefe Servicio UGC Oncología Dr. en Medicina
  • Sánchez Gastaldo, Amparo.Lda. en Medicina y Cirugía
  • Valdivia Ferreira, María Luisa.Técnica de Laboratorio de Diagnóstico Clínico, Patología y Citología
  • Valladares Ayerbes, Manuel .Dr. en Medicina y Cirugía
  • Vieites Pérez-Quintela, Begoña.Dra. en Medicina y Cirugía

Research areas

International Journals
Gonzalez-Cao, M; Moran, T; Dalmau, J; Garcia-Corbacho, J; Bracht, JWP; Bernabe, R; Juan, OS; de Castro, J; Blanco, R; Drozdowskyj, A; Argilaguet, J; Meyerhans, A; Blanco, J; Prado, JG; Carrillo, J; Clotet, B; Massuti, B; Provencio, M; Molina-Vila, MA; de las Casa, CM; Garzon, M; Cao, P; Huang, CY; Martinez-Picado, J; Rosell, R
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection The Phase 2 DURVAST Study
JAMA ONCOLOGY
Gonzalez-Santiago, S; Saura, C; Ciruelos, E; Alonso, JL; de la Morena, P; Eslava, MS; Sancho, MIG; de Luna, A; Dalmau, E; Servitja, S; Borrego, MR; Chacon, JI
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)
BREAST CANCER RESEARCH AND TREATMENT
Gavila, J; De La Haba, J; Bermejo, B; Rodriguez-Lescure, A; Anton, A; Ciruelos, E; Brunet, J; Munoz-Couselo, E; Santisteban, M; Sanchez, CAR; Santaballa, A; Rovira, PS; Saenz, JAG; Ruiz-Borrego, M; Guerrero-Zotano, AL; Huerta, M; Cotes-Sanchis, A; Romera, JL; Aguirre, E; Cortes, J; Llombart-Cussac, A
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
CLINICAL & TRANSLATIONAL ONCOLOGY
Perez-Ruiz, E; Jimenez-Castro, J; Berciano-Guerrero, MA; Valdivia, J; Estalella-Mendoza, S; Toscano, F; Artacho, MRD; Garrido-Siles, M; Martinez-Bautista, MJ; Roldan, RV; Rivas-Ruiz, F; Nogales-Fernandez, E; Morales, C; Perez-Valderrama, B; De la Cruz-Merino, L; Rueda, A
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
CLINICAL & TRANSLATIONAL ONCOLOGY
Barcenas, CH; Hurvitz, SA; Di Palma, JA; Bose, R; Chien, AJ; Iannotti, N; Marx, G; Brufsky, A; Litvak, A; Ibrahim, E; Alvarez, RH; Ruiz-Borrego, M; Chan, N; Manalo, Y; Kellum, A; Trudeau, M; Thirlwell, M; Saenz, JG; Hunt, D; Bryce, R; McCulloch, L; Rugo, HS; Tripathy, D; Chan, A
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial
ANNALS OF ONCOLOGY
Manso, L; Hernando, C; Galan, M; Oliveira, M; Cabrera, MA; Bratos, R; Rodriguez, CA; Ruiz-Borrego, M; Blanch, S; Llombart-Cussac, A; Delgado-Mingorance, JI; Alvarez-Busto, I; Gallegos, I; Gonzalez-Cortijo, L; Morales, S; Aguirre, E; Hernando, BA; Ballesteros, A; Ales-Martinez, JE; Reboredo, C; Oltra, A; Gonzalez-Cao, M; Santisteban, M; Malon, D; Echeverria, I; Garcia-Garre, E; Vega, E; Servitja, S; Andres, R; Robles, CE; Lopez, R; Galve, E; Echarri, MJ; Legeren, M; Moreno, F
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
BREAST
Barquin, M; Calvo, V; Garcia-Garcia, F; Nunez, B; Sanchez-Herrero, E; Serna-Blasco, R; Auglyt, M; Carcereny, E; Rodriguez-Abreu, D; Castro, RL; Guirado, M; Camps, C; Bosch-Barrera, J; Massuti, B; Ortega, AL; del Barco, E; Gonzalez-Larriba, JL; Aguiar, D; Garcia-Campelo, R; Domine, M; Agraso, S; Sala, MA; Oramas, J; Bernabe, R; Blanco, R; Parejo, C; Cruz, A; Menasalvas, E; Royuela, A; Romero, A; Provencio, M
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation
CANCER EPIDEMIOLOGY
Cortes, J; Ciruelos, E; Perez-Garcia, J; Albanell, J; Garcia-Estevez, L; Ruiz-Borrego, M; Espinosa, R; Gallegos, I; Gonzalez, S; Alvarez, I; Llombart, A
Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients
CANCER TREATMENT REVIEWS
Quintanal-Villalonga, A; Ferrer, I; Guruceaga, E; Cirauqui, C; Marrugal, A; Ojeda, L; Garcia, S; Zugazagoitia, J; Munoz-Galvan, S; Lopez-Rios, F; Montuenga, L; Vicent, S; Molina-Pinelo, S; Carnero, A; Paz-Ares, L
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
EBIOMEDICINE
Garcia-Campelo, R; Arrieta, O; Massuti, B; Rodriguez-Abreu, D; Granados, ALO; Majem, M; Vicente, D; Lianes, P; Bosch-Barrera, J; Insa, A; Domine, M; Reguart, N; Guirado, M; Sala, MA; Vazquez-Estevez, S; Caro, RB; Drozdowskyj, A; Verdu, A; Karachaliou, N; Molina-Vila, MA; Rosell, R
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)
LUNG CANCER
Provencio, M; Nadal, E; Insa, A; Garcia-Campelo, MR; Casal-Rubio, J; Domine, M; Majem, M; Rodriguez-Abreu, D; Martinez-Marti, A; Carpeno, JD; Cobo, M; Vivanco, GL; Del Barco, E; Caro, RB; Vinolas, N; Aranda, IB; Viteri, S; Pereira, E; Royuela, A; Casarrubios, M; Anton, CS; Parra, ER; Wistuba, I; Calvo, V; Laza-Briviesca, R; Romero, A; Massuti, B; Cruz-Bermudez, A
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
LANCET ONCOLOGY
Gasca, J; Flores, ML; Jimenez-Guerrero, R; Saez, ME; Barragan, I; Ruiz-Borrego, M; Tortolero, M; Romero, F; Saez, C; Japon, MA
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin alpha(V)beta(3)in cancer cells
CELL DEATH DISCOVERY
Leskela, S; Romero, I; Cristobal, E; Perez-Mies, B; Rosa-Rosa, JM; Gutierrez-Pecharroman, A; Santon, A; Gonzalez, BO; Lopez-Reig, R; Hardisson, D; Vera-Sempere, F; Illueca, C; Vieites, B; Lopez-Guerrero, JA; Palacios, J; Poveda, A
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Vallejo, A; Molina-Pinelo, S; de Felipe, B; Abad-Fernandez, M; Gonzalez-Escribano, MF; Leal, M; Soriano-Sarabia, N
Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
de las Heras, BB; Cajal, JCRY; Calvo, EG; Rodriguez, JD; Mata, JG; Anton, FM; Fernandez, IP; Rodriguez-Lescure, A; Sanchez, CAR; Ruiz-Borrego, M; Remak, E; Barra, M; Rivero, M; Alvarez, JS
The economic burden of metastatic breast cancer in Spain
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
Lluch, A; Barrios, CH; Torrecillas, L; Ruiz-Borrego, M; Bines, J; Segalla, J; Guerrero-Zotano, A; Garcia-Saenz, JA; Torres, R; de la Haba, J; Garcia-Martinez, E; Gomez, HL; Llombart, A; Bofill, JS; Baena-Canada, JM; Barnadas, A; Calvo, L; Perez-Michel, L; Ramos, M; Fernandez, I; Rodriguez-Lescure, A; Cardenas, J; Vinholes, J; de Duenas, EM; Godes, MJ; Segui, MA; Anton, A; Lopez-Alvarez, P; Moncayo, J; Amorim, G; Villar, E; Reyes, S; Sampaio, C; Cardemil, B; Escudero, MJ; Bezares, S; Carrasco, E; Martin, M; Corona, J; Jara, C; Cardemil, B; Toro, R; Pimentel, C; Hernando, B; Vicente, E; Zagame, L; Gil, M; Estevez, LG; Rodriguez, C; de la Cruz, MA; Tello, JM; Campos, S; Lomas, M; Capdevile, D; Campos, M; Margeli, M; Andres, R; Tusquets, I; Ballesteros, A; Guerrero, A; Arguello, M; Rodriguez, JL; Munoz, M; Florian, J; Azevedo, S; Mondragon, R; Peralta, J; Palomo, AE; Barajas, LJ; Arcusa, A; Carranza, H; Garcia, C; Umbria, C; Ales, JE; Vega, JML; Romeo, M; Valero, J; Alonso, JL; Mathias, C; Gutierrez, F; Adrover, E; Nunez, P; Mendiola, C; Cassinello, J; de la Huerta, A
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
JOURNAL OF CLINICAL ONCOLOGY
Grande, E; Teule, A; Alonso-Gordoa, T; Jimenez-Fonseca, P; Benavent, M; Capdevila, J; Custodio, A; Vera, R; Munarriz, J; La Casta, A; Diez, JJ; Gajate, P; Molina-Cerrillo, J; Matos, I; Cristobal, EM; Ruffinelli, JC; Palacios, J; Garcia-Carbonero, R
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)
ONCOLOGIST
Penate, X; Praena-Fernandez, JM; Pareja, PR; Enguix-Riego, MD; Payan-Bravo, L; Vieites, B; Gomez-Izquierdo, L; Olasolo, JJ; del Campo, ER; Reyes, JC; Chavez, S; Lopez Guerra, JL
Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer
CANCERS
Lopez-Garcia, MA; Carretero-Barrio, I; Perez-Mies, B; Chiva, M; Castilla, C; Vieites, B; Palacios, J
Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
CANCERS
Noguera-Ucles, JF; Boyero, L; Salinas, A; Varela, JAC; Benedetti, JC; Bernabe-Caro, R; Sanchez-Gastaldo, A; Alonso, M; Paz-Ares, L; Molina-Pinelo, S
The Roles of ImprintedSLC22A18andSLC22A18ASGene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients
CANCERS
Boyero, L; Sanchez-Gastaldo, A; Alonso, M; Noguera-Ucles, JF; Molina-Pinelo, S; Bernabe-Caro, R
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
CANCERS
Hindi, N; Garcia, IC; Sanchez-Camacho, A; Gutierrez, A; Peinado, J; Rincon, I; Benedetti, J; Sancho, P; Santos, P; Sanchez-Bustos, P; Marcilla, D; Encinas, V; Chacon, S; Munoz-Casares, C; Moura, D; Martin-Broto, J
Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
CANCERS
Balana, C; Vaz, MA; Sepulveda, JM; Mesia, C; del Barco, S; Pineda, E; Munoz-Langa, J; Estival, A; de las Penas, R; Fuster, J; Girones, R; Navarro, LM; Gil-Gil, M; Alonso, M; Herrero, A; Peralta, S; Olier, C; Perez-Segura, P; Covela, M; Martinez-Garcia, M; Berrocal, A; Gallego, O; Luque, R; Perez-Martin, FJ; Esteve, A; Munne, N; Domenech, M; Villa, S; Sanz, C; Carrato, C
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
NEURO-ONCOLOGY
Sansano, I; Vieites, B; de Salas, MS; Garcia, C; Amendoeira, I; Bernet, L; Perez-Garcia, JM; Espinosa-Bravo, M; Rubio, IT; Cajal, SRY; Peg, V
Axillary staging based on molecular analysis: Results of the B-CLOSER-II study
PATHOLOGY RESEARCH AND PRACTICE
Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O'Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med.
Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.
J Clin Oncol.
Castro E, Romero-Laorden N, Del Pozo A, Lozano R, Medina A, Puente J, Piulats JM, Lorente D, Saez MI, Morales-Barrera R, Gonzalez-Billalabeitia E, Cendón Y, García-Carbonero I, Borrega P, Mendez Vidal MJ, Montesa A, Nombela P, Fernández-Parra E, Gonzalez Del Alba A, Villa-Guzmán JC, Ibáñez K, Rodriguez-Vida A, Magraner-Pardo L, Perez-Valderrama B, Vallespín E, Gallardo E, Vazquez S, Pritchard CC, Lapunzina P, Olmos D
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol.
Zugazagoitia J, Ramos I, Trigo JM, Palka M, Gómez-Rueda A, Jantus-Lewintre E, Camps C, Isla D, Iranzo P, Ponce-Aix S, García-Campelo R, Provencio M, Franco F, Bernabé R, Juan-Vidal O, Felip E, de Castro J, Sanchez-Torres JM, Faul I, Lanman RB, Garrido P, Paz-Ares L
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
Ann Oncol.
Quintanal-Villalonga A, Molina-Pinelo S, Cirauqui C, Ojeda-Márquez L, Marrugal Á, Suarez R, Conde E, Ponce-Aix S, Enguita AB, Carnero A, Ferrer I, Paz-Ares L
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy.
J Thorac Oncol.
Joel Martin-Padron, Laura Boyero, Maria Isabel Rodriguez, Alvaro Andrades, Inés Díaz-Cano, Paola Peinado, Carlos Baliñas, Juan Carlos Alvarez-Perez, Isabel F. Coira, and Mª Esther Fárez-Vidal, Pedro P.
Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer.
Medina Oncogene.
Solis-Hernandez MP, Fernandez Del Valle A, Carmona-Bayonas A, Garcia-Carbonero R, Custodio A, Benavent M, Alonso Gordoa T, Nuñez-Valdovino B, Sanchez Canovas M, Matos I, Alonso V, Lopez C, Viudez A, Izquierdo M, Calvo-Temprano D, Grande E, Capdevila J, Jimenez-Fonseca P
Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study).
Br J Cancer.
Molina J, Noguer M, Lepe JA, Pérez-Moreno MA, Aguilar-Guisado M, Lasso de la Vega R, Peñalva G, Crespo-Rivas JC, Gil-Navarro MV, Salvador J, Cisneros JM
Clinical impact of an educational antimicrobial stewardship program associated with infectious diseases consultation targeting patients with cancer: Results of a 9-year quasi-experimental study with an interrupted time-series analysis.
J Infect.
Pecero ML, Salvador-Bofill J, Molina-Pinelo S
Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
Cell Oncol (Dordr).
Quintanal-Villalonga Á, Molina-Pinelo S
Epigenetics of lung cancer: a translational perspective.
Cell Oncol (Dordr).
Marrugal Á, Ferrer I, Pastor MD, Ojeda L, Quintanal-Villalonga Á, Carnero A, Molina-Pinelo S, Paz-Ares L
Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Cells.
Provencio M, Carcereny E, Rodríguez-Abreu D, López-Castro R, Guirado M, Camps C, Bosch-Barrera J, García-Campelo R, Ortega-Granados AL, González-Larriba JL, Casal-Rubio J, Domine M, Massutí B, Sala MÁ, Bernabé R, Oramas J, Del Barco E
Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study).
Transl Lung Cancer Res.
Quintanal-Villalonga A, Molina-Pinelo S, Yagüe P, Marrugal Á, Ojeda-Márquez L, Suarez R, Ponce-Aix S, Enguita AB, Carnero A, Ferrer I, Paz-Ares L
FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective.
Lung Cancer.
Zugazagoitia J, Gómez-Rueda A, Jantus-Lewintre E, Isla D, Camps C, Ramos I, Trigo JM, Bernabé R, Juan-Vidal O, Sanchez-Torres JM, García-Campelo R, Provencio M, Felip E, de Castro J, Faull I, Lanman RB, Ponce-Aix S, Paz-Ares L, Garrido P
Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance.
Lung Cancer.
Quintanal-Villalonga A, Ferrer I, Molina-Pinelo S, Paz-Ares L
A patent review of FGFR4 selective inhibition in cancer (2007-2018).
Expert Opin Ther Pat.
Font A, Luque R, Villa JC, Domenech M, Vázquez S, Gallardo E, Virizuela JA, Beato C, Morales-Barrera R, Gelabert A, Maciá S, Puente J, Rubio G, Maldonado X, Perez-Valderrama B, Pinto A, Fernández Calvo O, Grande E, Garde-Noguera J, Fernández-Parra E, Arranz JÁ
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Target Oncol.
Picornell AC, Echavarria I, Alvarez E, López-Tarruella S, Jerez Y, Hoadley K, Parker JS, Del Monte-Millán M, Ramos-Medina R, Gayarre J, Ocaña I, Cebollero M, Massarrah T, Moreno F, García Saenz JA, Gómez Moreno H, Ballesteros A, Ruiz Borrego M, Perou CM, Martin M
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.
BMC Genomics.
Aapro M, Ruiz-Borrego M, Hegg R, Kukielka-Budny B, Morales S, Cinieri S, Freitas-Junior R, Garcia-Estevez L, Szombara E, Borges GS, Passalacqua R, Hervieu H, Groc M, Villanova G
Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial).
Breast.
Ocana A, Gil-Martin M, Antolín S, Atienza M, Montaño Á, Ribelles N, Urruticoechea A, Falcón A, Pernas S, Orlando J, Montero JC, Escudero MJ, Benito S, Caballero R, Carrasco E, Rojo F, Pandiella A, Ruiz-Borrego M
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat.
Ruíz-Borrego M, Guerrero-Zotano A, Bermejo B, Ramos M, Cruz J, Baena-Cañada JM, Cirauqui B, Rodríguez-Lescure Á, Alba E, Martínez-Jáñez N, Muñoz M, Antolín S, Álvarez I, Del Barco S, Sevillano E, Chacón JI, Antón A, Escudero MJ, Ruiz V, Carrasco E, Martín M, GEICAM
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat.
Ruiz-Borrego M, Jimenez B, Antolín S, García-Saenz JA, Corral J, Jerez Y, Trigo J, Urruticoechea A, Colom H, Gonzalo N, Muñoz C, Benito S, Caballero R, Bezares S, Carrasco E, Rojo F, Martín M
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.
Invest New Drugs.
González Del Alba A, De Velasco G, Lainez N, Maroto P, Morales-Barrera R, Muñoz-Langa J, Pérez-Valderrama B, Basterretxea L, Caballero C, Vazquez S
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
Clin Transl Oncol.
González-Flores E, Serrano R, Sevilla I, Viúdez A, Barriuso J, Benavent M, Capdevila J, Jimenez-Fonseca P, López C, Garcia-Carbonero R
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
Clin Transl Oncol.
Ciruelos EM, Díaz MN, Isla MD, López R, Bernabé R, González E, Cirauqui B, Coves J, Morales S, Arcediano A, Barneto I, Cerezuela P, Illarramendi JJ, Morales C, Ponce S
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.
Eur J Cancer Care (Engl).
Rodriguez-Rodriguez A, Boyero L, Sempere L, Vilches-Arenas A
Animal models for neurotoxicity assessment in cardiac arrest.
Med Intensiva.
Sempere L, Rodríguez-Rodríguez A, Boyero L, Egea-Guerrero JJ
Experimental models in traumatic brain injury: from animal models to in vitro assays.
Med Intensiva.
de Francisco ALM, Arias Guillén M, Pérez-Valderrama B, Sebastia C
Post-contrast acute kidney injury in cancer patients.
Nefrologia.
Barnadas A, Muñoz M, Margelí M, Chacón JI, Cassinello J, Antolin S, Adrover E, Ramos M, Carrasco E, Jimeno MA, Ojeda B, González X, González S, Constenla M, Florián J, Miguel A, Llombart A, Lluch A, Ruiz-Borrego M, Colomer R, Del Barco S, GEICAM, Spanish Breast Cancer Group
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study.
J Patient Rep Outcomes.
Sánchez-Rovira P, Zamora P, Salvador-Bofill J, Morales S, Martínez-Jáñez N, Martínez-de-Dueñas E, Lluch A, Illarramendi JJ, Gómez-Pardo P, Gavilá Gregori J, García-Palomo A, García-Mata J, Fernández Y, Del Barco S, de Juan A, Ciruelos E, Chacón JI, Calvo L, Barnadas A, Albanell J
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess.
Herrero Rivera D, Nieto-Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, Delgado D, Rivin Del Campo E, Praena-Fernández JM, Bernabé Caro R, Ortiz Gordillo MJ, Fernández Fernández MC, Lopez Guerra JL.
Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment.
Clin Transl Oncol
Vicente Guillem, Francisco Javier Salvador Bofill, Margarita Feyjoo, Antonio Antón, Enrique Aranda, Carlos Camps, Alfredo Carrato, Manuel Constenla, Juan Jesús Cruz-Hernández, Eduardo Díaz-Rubio, Jesús García-Foncillas, Pere Gascón, Rafael López, Begoña Soler, Yolanda Escobar Open J Pain
Clinical practice evaluation of opioids induced constipation management in patients with cancer: The EIO-50 project
Medicine.
Books and articles in books
Escudero-Ávila R, Rodríguez-Castaño JD, Osman I, Fernandez F, Medina R, Vargas B, Japón-Rodríguez M, Sancho P, Perez-Valderrama B, Praena-Fernández JM, Duran I
Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
Clin Transl Oncol.